Can You Take GLP-1 Medication While Trying to Conceive or Breastfeeding?
GLP-1 medications may improve fertility — but must be stopped 2 months before conceiving. Here's the complete guide to medication and family planning.
If you're thinking about getting pregnant — or currently breastfeeding — and also considering GLP-1 medication, the safety question is critical. Here's what the research says, what the FDA recommends, and how to plan your treatment timeline around family planning.
GLP-1 Medications and Pregnancy: The Clear Rule
GLP-1 medications should not be used during pregnancy. This is the unambiguous FDA recommendation. Semaglutide and tirzepatide carry pregnancy category warnings based on animal studies showing potential fetal harm, including increased risk of birth defects and pregnancy loss at high doses.
The recommendation: stop GLP-1 medication at least 2 months before trying to conceive. Semaglutide has a half-life of approximately one week, so it takes several weeks to fully clear your system. The 2-month buffer provides an adequate washout period.
GLP-1 Medications and Fertility: The Unexpected Connection
Here's the complicated part: while GLP-1 medications shouldn't be used during pregnancy, they may actually improve fertility before pregnancy. Weight loss — by any method — improves fertility outcomes for people with obesity-related infertility.
Specific fertility-relevant effects of GLP-1 medications:
- PCOS improvement: Weight loss of 5–10% can restore ovulatory cycles in women with polycystic ovary syndrome. GLP-1 medications frequently achieve this level of weight loss.
- Hormonal normalization: Excess body fat produces estrogen and disrupts hormonal balance. Weight loss normalizes estrogen, testosterone, and reproductive hormone levels.
- Improved IVF outcomes: Some fertility specialists are using GLP-1 medications as part of pre-IVF weight optimization protocols — helping patients reach a healthier BMI before starting fertility treatment.
There are anecdotal reports of unexpected pregnancies in patients on GLP-1 medication — sometimes called "Ozempic babies" in popular media. The likely explanation: improved ovulation in patients who were previously anovulatory due to weight-related hormonal disruption, combined with GLP-1 medications potentially reducing the effectiveness of oral contraceptives (due to delayed gastric absorption).
If You're Planning Pregnancy
- Discuss your timeline with your provider before starting GLP-1 medication
- Use reliable contraception while on GLP-1s (non-oral methods may be more reliable given potential absorption effects)
- Plan a 2-month washout period between stopping medication and actively trying to conceive
- Work with your provider to transition to a weight maintenance plan during the washout period
- If you discover you're pregnant while on GLP-1 medication, stop immediately and contact your OB-GYN
GLP-1 Medications and Breastfeeding
GLP-1 medications are not recommended during breastfeeding. Limited data exists on whether semaglutide or tirzepatide passes into breast milk, but the precautionary principle applies: the potential risk to the infant outweighs the benefit of continued weight loss medication during lactation.
Postpartum weight loss goals can be addressed after breastfeeding ends, or through non-pharmacological approaches during breastfeeding.
GLP-1 medications can improve fertility through weight loss — but must be stopped before conception and avoided during pregnancy and breastfeeding. If family planning is in your near future, work with your provider to create a treatment timeline that maximizes the fertility benefits of weight loss while ensuring medication is cleared before pregnancy.